What is the most recent earnings date for NKTR stock?
NEKTAR THERAPEUTICS (NKTR) last reported earnings on 3/12/2026.
NEKTAR THERAPEUTICS (NKTR) Earnings History & Surprises
NASDAQ:NKTR • US6402683063
Current stock price
72.21 USD
-1.04 (-1.42%)
At close:
72.69 USD
+0.48 (+0.66%)
Pre-Market:
NKTR Earnings overview
Past quarterly earnings results for NEKTAR THERAPEUTICS (NKTR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$2.00
- Revenue Estimate
- 9.854M
Last Reported
Most Recent- Release Date
- Mar 12, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$1.78
- EPS Surprise
- 29.47%
- Revenue Surprise
- 105.49%
Beat Rate
Last 8 Quarters 69%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -1.78 | -2.52 | 29.47% | 25.83% | 21.807M | 10.612M | 105.49% | -25.25% |
| Q3 2025 | -1.87 | -2.74 | 31.71% | 30.74% | 11.79M | 10.249M | 15.04% | -51.13% |
| Q2 2025 | -2.95 | -3.10 | 4.71% | 21.33% | 11.175M | 11.066M | 0.98% | -52.42% |
| Q1 2025 | -3.60 | -2.51 | -43.22% | -26.32% | 10.446M | 15.664M | -33.31% | -51.73% |
| Q4 2024 | -2.40 | -2.57 | 6.77% | 27.27% | 29.175M | 30.457M | -4.21% | 22.15% |
| Q3 2024 | -2.70 | -3.23 | 16.31% | 25.00% | 24.124M | 18.646M | 29.38% | -0.08% |
| Q2 2024 | -3.75 | -3.12 | -20.38% | 7.41% | 23.489M | 17.896M | 31.25% | 14.59% |
| Q1 2024 | -2.85 | -2.91 | 1.96% | 40.62% | 21.639M | 15.649M | 38.28% | 0.21% |
| Q4 2023 | -3.30 | -3.25 | -1.55% | 31.25% | 23.885M | 18.416M | 29.70% | 8.57% |
| Q3 2023 | -3.60 | -3.05 | -17.98% | 22.58% | 24.144M | 21.739M | 11.06% | 2.31% |
| Q2 2023 | -4.05 | -4.34 | 6.75% | 68.24% | 20.499M | 22.263M | -7.92% | -5.10% |
| Q1 2023 | -4.80 | -3.86 | -24.21% | 34.69% | 21.594M | 20.235M | 6.72% | -12.93% |
| Q4 2022 | -4.80 | -6.92 | 30.65% | 59.49% | 22M | 22.576M | -2.55% | -12.00% |
| Q3 2022 | -4.65 | -6.88 | 32.39% | 55.71% | 23.6M | 23.061M | 2.34% | -5.22% |
| Q2 2022 | -12.75 | -14.32 | 10.99% | -23.19% | 21.6M | 23.118M | -6.57% | -23.67% |
| Q1 2022 | -7.35 | -10.36 | 29.07% | 26.87% | 24.8M | 24.865M | -0.26% | 5.08% |
| Q4 2021 | -11.85 | -12.38 | 4.31% | -21.54% | 25M | 25.84M | -3.25% | 6.38% |
| Q3 2021 | -10.50 | -12.21 | 14.04% | -14.75% | 24.9M | 28.425M | -12.40% | -17.00% |
| Q2 2021 | -10.35 | -11.18 | 7.44% | -53.33% | 28.3M | 26.5M | 6.79% | -42.01% |
| Q1 2021 | -10.05 | -11.05 | 9.02% | -26.42% | 23.6M | 27.442M | -14.00% | -53.36% |
| Q4 2020 | -9.75 | -10.40 | 6.27% | - | 23.5M | 30.615M | -23.24% | - |
| Q3 2020 | -9.15 | -11.32 | 19.14% | - | 30M | 26.859M | 11.69% | - |
| Q2 2020 | -6.75 | -10.47 | 35.53% | - | 48.8M | 23.255M | 109.85% | - |
| Q1 2020 | -7.95 | -11.80 | 32.63% | - | 50.6M | 48.595M | 4.13% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
-0.01%
Max EPS beat (4)
31.71%
Min EPS beat (4)
-43.22%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
-5.38%
Max Revenue beat (4)
15.04%
Min Revenue beat (4)
-33.31%
Analysis
In the last 4 quarters, NKTR has beaten EPS estimates in 3 out of 4 releases
NKTR has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, NKTR reported -0.0% below the EPS estimates on average.
In the last 4 quarters, NKTR reported -5.4% below the revenue estimates on average.
Related analysis
NEKTAR THERAPEUTICS / NKTR Earnings FAQ
Did NKTR stock beat earnings estimates in the most recent quarter?
NEKTAR THERAPEUTICS (NKTR) beat EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often NEKTAR THERAPEUTICS beats earnings estimates?
In the last 4 quarters, NEKTAR THERAPEUTICS (NKTR) has beaten EPS estimates in 3 out of 4 releases.